Study on Optimal Extraction and Hypoglycemic Effect of Quercetin

Area of Science:

• Pharmacology
• Natural Product Chemistry
• Metabolic Diseases

Background:

• Type 2 diabetes is a growing global health concern.
• Dipeptidyl peptidase IV (DPP-IV) is a key target for managing type 2 diabetes.
• Natural compounds are being explored for their therapeutic potential in diabetes.

Purpose of the Study:

• To extract quercetin from Portulaca oleracea L.
• To evaluate the hypoglycemic effects of quercetin in a type 2 diabetic mouse model.
• To investigate quercetin's inhibitory effect on DPP-IV activity.

Main Methods:

• Optimized quercetin extraction from Portulaca oleracea L. using response surface methodology (RSM).
• Established a type 2 diabetic mouse model for oral quercetin administration.
• Assessed fasting blood glucose, serum DPP-IV activity, body weight, insulin levels, and performed oral glucose tolerance tests.

Main Results:

• Optimized extraction yielded 0.675% quercetin.
• Quercetin treatment significantly reduced fasting blood glucose and serum DPP-IV activity.
• Quercetin increased body weight and insulin levels, and dose-dependently improved glucose tolerance.

Conclusions:

• Quercetin extracted from Portulaca oleracea L. demonstrates significant hypoglycemic effects.
• Quercetin improves insulin sensitivity in type 2 diabetic mice, likely through DPP-IV inhibition.
• This study supports quercetin as a potential therapeutic agent for type 2 diabetes.